ACTIVE

KING KONG

Financial year 2025 · closed on 31/12/2025
Net result
452,8 k €
-3.6% YoY
Gross margin
1,5 M €
+5.3% YoY
Equity
1,7 M €
+19.3% YoY
Workforce
10,8 ETP
+9.1% YoY

What does KING KONG do?

KING KONG is a Private limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bertem. It employs on average 10,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0861.554.394
Incorporation
07/11/2003
Legal form
Private limited company
Registered office
Tervuursesteenweg 69 box 01
3060 Bertem · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Average workforce
10,8 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 19 financial years

2025202420232022202120202019201820172016201520142013201220112010200920082007
Income statement
Gross margin1,5 M €1,4 M €1,2 M €1,1 M €914,5 k €290,9 k €369,7 k €298,7 k €387,7 k €418,8 k €404,8 k €119,3 k €134,8 k €75,3 k €7 k €3,4 k €-14 k €10,3 k €18,2 k €
EBITDA763,9 k €766,4 k €404,7 k €594,8 k €456,3 k €16,3 k €188,6 k €136,8 k €202,5 k €205 k €181,4 k €37,9 k €133,8 k €74,1 k €5,9 k €3,3 k €-14,1 k €10,2 k €18 k €
Operating result722,9 k €740,7 k €327,4 k €589,2 k €448,6 k €11,6 k €183,6 k €129,8 k €196,2 k €202,8 k €181,4 k €37,9 k €133,8 k €74,1 k €5,7 k €-1,4 k €-18,8 k €5,4 k €13,6 k €
Net result452,8 k €469,5 k €160,3 k €380 k €283,5 k €-9,2 k €115,2 k €78,4 k €118 k €115,8 k €118,2 k €26,6 k €89,8 k €50,6 k €3,4 k €-3,3 k €6,2 k €22,4 k €6,9 k €
Balance sheet
Equity1,7 M €1,5 M €995,1 k €1 M €765,1 k €481,6 k €490,8 k €375,7 k €408,8 k €290,8 k €175 k €236,7 k €222,5 k €132,7 k €82,2 k €78,8 k €82 k €75,8 k €53,3 k €
Total assets4,2 M €4,5 M €4,3 M €3,7 M €3,4 M €3,3 M €808,4 k €666,2 k €604,6 k €450 k €488,1 k €327,8 k €278,4 k €299,7 k €234,4 k €230,1 k €145,4 k €156,6 k €129,2 k €
Cash94,5 k €201,6 k €209,2 k €244,4 k €184,2 k €79,9 k €27 k €17,1 k €75,4 k €86,9 k €204,8 k €40,1 k €35,5 k €74,9 k €24 k €16,6 k €1,9 k €3,2 k €2,2 k €
Debts2,5 M €3 M €3,2 M €2,7 M €2,6 M €2,8 M €315,8 k €289,5 k €195,3 k €150,7 k €305,8 k €88,7 k €55,8 k €166,2 k €152,1 k €150,9 k €63 k €80,5 k €75,7 k €
Other
Workforce10,8 ETP9,9 ETP10,1 ETP9,8 ETP9,9 ETP5,5 ETP4,2 ETP3,2 ETP4,0 ETP5,1 ETP4,3 ETP4,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

Katrien Vermylen

Director · since 01 juillet 2013

Active
Stefaan Kinget

Director

Active

Ended mandates

Stefaan Kinget

Manager · since 31 octobre 2003

Ended
Stefaan Kinget

Director · since 13 octobre 2003

Ended
ANNE CLEEREN FARMA

Mandate · 0663.888.289

Represented by ANNA CLEEREN

Ended
ANNE CLEEREN FARMA

Director · 0663.888.289

Represented by Anne Cleeren

Ended
At this address

Other companies at this address

CompanyCBE no.
0861.501.342
King InvestActive
0458.404.281
KING SUPPLYActive
0804.268.372
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/07/202201/07/202101/07/202001/07/2019
Closing of the financial year31/12/202531/12/202431/12/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months18 months12 months12 months12 months
Filing date13/05/202625/06/202527/06/202412/01/202330/11/202108/12/2020
General meeting05/05/202615/06/202515/06/202425/11/202226/11/202127/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

19 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/05/202613/05/2026DutchPDF
Abridged model31/12/202415/06/202525/06/2025DutchPDF
Abridged model31/12/202315/06/202427/06/2024DutchPDF
Abridged model30/06/202225/11/202212/01/2023DutchPDF
Abridged model30/06/202126/11/202130/11/2021DutchPDF
Abridged model30/06/202027/11/202008/12/2020DutchPDF
Abridged model30/06/201922/11/201926/11/2019DutchPDF
Abridged model30/06/201823/11/201828/11/2018DutchPDF
Abridged model30/06/201727/11/201707/12/2017DutchPDF
Abridged model30/06/201625/11/201601/12/2016DutchPDF
Abridged model30/06/201527/11/201530/11/2015DutchPDF
Abridged model30/06/201428/11/201401/12/2014DutchPDF
Abridged model30/06/201322/11/201325/11/2013DutchPDF
Abridged model30/06/201231/12/201208/01/2013DutchPDF
Abridged model30/06/201131/12/201116/01/2012DutchPDF
Abridged model30/06/201026/11/201021/02/2011DutchPDF
Abridged model30/06/200927/11/200922/01/2010DutchPDF
Abridged model30/06/200828/11/200823/02/2009DutchPDF
Abridged model30/06/200723/11/200731/01/2008DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

Katrien Vermylen

Director · since 01 juillet 2013

Active
Stefaan Kinget

Director

Active

Ended mandates

Stefaan Kinget

Manager · since 31 octobre 2003

Ended
Stefaan Kinget

Director · since 13 octobre 2003

Ended
ANNE CLEEREN FARMA

Mandate · 0663.888.289

Represented by ANNA CLEEREN

Ended
ANNE CLEEREN FARMA

Director · 0663.888.289

Represented by Anne Cleeren

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Restructuring26/06/2026
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates05/07/2023
    WIJZIGING RECHTSVORM - BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates22/10/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares16/01/2018
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates07/01/2014
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/07/2013
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other10/10/2012
    DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Registered office22/10/2007
    MAATSCHAPPELIJKE ZETEL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025452,8 k €
  2. 2024
    Annual accounts 2024469,5 k €
  3. 2023
    Annual accounts 2023160,3 k €
  4. 2023
    Name changeKING KONG
  5. 2022
    Annual accounts 2022380 k €
  6. 2022
    Name changeStefarm
  7. 2021
    Annual accounts 2021283,5 k €
  8. 2020
    Annual accounts 2020-9,2 k €
  9. 2019
    Annual accounts 2019115,2 k €
  10. 2018
    Annual accounts 201878,4 k €
  11. 2017
    Annual accounts 2017118 k €
  12. 2016
    Annual accounts 2016115,8 k €
  13. 2015
    Annual accounts 2015118,2 k €
  14. 2014
    Annual accounts 201426,6 k €
  15. 2013
    Annual accounts 201389,8 k €
  16. 2012
    Annual accounts 201250,6 k €
  17. 2011
    Annual accounts 20113,4 k €
  18. 2010
    Annual accounts 2010-3,3 k €
  19. 2009
    Annual accounts 20096,2 k €
  20. 2008
    Annual accounts 200822,4 k €
  21. 2007
    Annual accounts 20076,9 k €
  22. 07/11/2003
    IncorporationPrivate limited company